PTGX · Protagonist Therapeutics, Inc
$150.59
-4.13 (-2.67%)
At close · Aug 25
Market Cap
$10.01B
Shares
64.71M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-05 | — | |
| 10-Q | 2026-08-05 | 2026-06-30 | |
| 8-K | 2026-06-18 | 2026-06-17 | |
| Investor Event Transcript | 2026-06-03 | 2026-06-30 | |
| 10-Q | 2026-05-05 | 2026-03-31 | |
| 8-K | 2026-05-05 | — | |
| DEF 14A | 2026-04-28 | 2026-06-17 | |
| Investor Event Transcript | 2026-03-31 | — | |
| 8-K | 2026-02-25 | — | |
| 10-K | 2026-02-25 | 2025-12-31 | |
| 8-K | 2026-01-12 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 10-Q | 2025-08-06 | 2025-06-30 | |
| 8-K | 2025-08-06 | — | |
| 8-K | 2025-06-26 | 2025-06-20 | |
| 8-K | 2025-05-06 | — | |
| 10-Q | 2025-05-06 | 2025-03-31 | |
| DEF 14A | 2025-04-29 | 2025-06-20 | |
| 8-K | 2025-03-20 | 2025-03-17 | |
| 8-K/A | 2025-03-11 | 2025-03-08 | |
| 8-K | 2025-03-10 | 2025-03-08 | |
| 8-K | 2025-03-03 | — | |
| 10-K | 2025-02-21 | 2024-12-31 | |
| 8-K | 2025-02-21 | — | |
| 8-K | 2025-01-06 | 2025-01-01 | |
| 8-K | 2024-11-18 | 2024-11-13 | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-11-07 | — | |
| 8-K | 2024-09-20 | 2024-09-17 | |
| 8-K | 2024-08-06 | — | |
| 10-Q | 2024-08-06 | 2024-06-30 | |
| 8-K | 2024-06-26 | 2024-06-20 | |
| 8-K | 2024-05-07 | — | |
| 10-Q | 2024-05-07 | 2024-03-31 | |
| DEF 14A | 2024-04-26 | 2024-06-20 | |
| 8-K | 2024-02-27 | — | |
| 10-K | 2024-02-27 | 2023-12-31 | |
| 8-K | 2024-01-31 | — | |
| 8-K | 2024-01-16 | 2024-01-09 | |
| 8-K | 2024-01-08 | — | |
| 10-Q | 2023-11-02 | 2023-09-30 | |
| 8-K | 2023-11-02 | — | |
| 8-K | 2023-10-30 | 2023-10-26 | |
| 8-K | 2023-08-03 | — | |
| 10-Q | 2023-08-03 | 2023-06-30 | |
| 8-K | 2023-07-05 | 2023-07-04 | |
| 8-K | 2023-07-03 | 2023-06-27 | |
| 8-K | 2023-05-30 | 2023-05-25 | |
| 10-Q | 2023-05-04 | 2023-03-31 |
Showing 1–50 of 104 filings
Key facts
CIK
1377121
CUSIP
74366E102
13F (30d)
304 filings
298 filers
Visit website
Investor relations